Press Releases

 Filter by Provider

Lincoln International, Inc. ("Lincoln International" or the "Company"), a global investment banking advisory firm, today announced that it has launched the roadshow for its initial public offering of 21,049,988 shares of its Class A common stock. The initial public offering price is currently expected to be between $18.00 and $20.00 per share. [Lincoln International’s Class A common stock has been approved for listing, subject to official notice of issuance, under the ticker symbol “LCLN” on the New York Stock Exchange.]

Central Garden & Pet Company (NASDAQ: CENT), (NASDAQ: CENTA), a leading consumer goods company in the pet and garden industries, today announced that members of its management team will participate in the following upcoming investor conferences and host meetings with institutional investors:

New Wearable SDR Broadens Mobilicom’s SkyHopper Product Portfolio Based on Evolving U.S. Department of War Operational Requirements

LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Camping World Holdings, Inc. (“Camping World” or “the Company”) (NYSE: CWH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Management to Discuss Mesabi Royalty Acquisition, Strategic Portfolio Construction, and 2026 Outlook

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced the initiation of a pilot study evaluating its novel on-demand 12-lead ECG patch in patients with suspected coronary artery disease. The study is being conducted at two leading hospitals in Belgrade, Serbia. The initiation of the pilot study represents a significant step in the development of the HeartBeam patch which has the potential to disrupt the long-term continuous monitor and mobile cardiac telemetry (MCT) markets.

Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced the purchase of a state‑of‑the‑art OLED Deposition System and all related equipment to establish full-scale OLED microdisplay production at the company’s Westborough, Massachusetts headquarters. The investment marks a significant evolution in Kopin’s manufacturing strategy and reflects the rapidly increasing demand for domestically produced OLED devices for U.S. defense applications.

SHELTON, CT / ACCESS Newswire / May 11, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the critical need for a revolutionary, broad-spectrum, antiviral drug like NV-387 in light of the recent Andes hantavirus incident on a cruise ship that has led to a flurry of worldwide activity to effectively quarantine the ship MV Hondius and trace passengers' contacts in an effort to prevent a potential global epidemic.

DENVER, CO / ACCESS Newswire / May 11, 2026 / Aimwell Partners (OTCID:AIMN) Brand, AimwellBio announced continued progress across its live demonstration, onboarding, and framework development initiatives tied to FHIN (Federated Health Intelligence Network), the company's evolving healthcare intelligence architecture designed to organize and contextualize complex scientific, regulatory, and healthcare-related signals.

-- Management Buy-Out Transaction ---- Gross Proceeds of $8.0 million ---- Cash at Close of $5.0 million plus Seller Notes of $3.0 million --

MCLEAN, VA / ACCESS Newswire / May 11, 2026 / Gladstone Investment Corporation (Nasdaq:GAIN) announces the following event:

Miami, Florida--(Newsfile Corp. - May 11, 2026) - Music Licensing, Inc. (OTCID: SONG), also known as Pro Music Rights, the...

Cimpress plc (Nasdaq: CMPR) has signed a definitive agreement with CEWE Stiftung & Co. KGaA to purchase its SAXOPRINT and viaprinto businesses (CEWE’s Commercial Online Print segment). Through this tuck-in acquisition, Cimpress will grow its manufacturing capabilities in Germany, and will also welcome two new customer-focused brands into its PrintBrothers segment of upload and print businesses.

Everlaw, the cloud-native investigation and litigation platform, today announced significant enhancements to its Legal Holds solution – including integrated questionnaires, a native Workday connector, expanded preservation-in-place integrations, and enhanced reporting and API capabilities – delivering a more automated, integrated approach to preservation for corporate legal teams.

Global Payments® (NYSE: GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, announced today that CKE Restaurants Holdings, Inc. – which operates the iconic Hardee’s and Carl’s Jr. quick service restaurant brands – has selected Global Payments as its exclusive U.S. point of sale (POS) and in-store payment solutions provider. CKE Restaurants will deploy Genius, Global Payments’ flagship POS and business management platform, at more than 2,400 corporate and franchise restaurant locations across the U.S.

ReNew Energy Global plc ("ReNew") (NASDAQ: RNW, RNWWW), India’s leading renewable energy company, today announced it will issue its fiscal fourth quarter (January - March) and year ended March 31, 2026, earnings report before the opening of the Nasdaq on May 18, 2026.

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced price increases for a range of acetyl products.

Hyliion Holdings Corp. (NYSE American: HYLN), a developer of modular power plant technology, today announced the successful demonstration of an uninterrupted multi-fuel transition in its next-generation KARNO™ reactor design, capable of handling liquid and gaseous fuels seamlessly. Operating without any hardware changes, the system transitioned through natural gas, hydrogen, diesel, and back to natural gas in a continuous sequence.

Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme® (pronounced “esteem”), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company’s entry into the international dermal filler market.

Pagaya Technologies Ltd. (NASDAQ: PGY) (“Pagaya”), a global technology company delivering AI-driven product solutions for the financial ecosystem, and Experian, a global data and technology company, announced a strategic partnership to embed Pagaya into Experian Marketplace, a leading shopping marketplace for credit cards, personal loans and auto insurance.

VanEck today announced that it will be the Exclusive ETF Partner of the Anglo American Padel Cup, set to take place in South Florida in February 2027.

Semify, a leading white-label digital marketing platform, today announced the launch of its AIO service, an AI Optimization service designed to help marketing agencies deliver comprehensive digital visibility to their clients. Semify’s AIO offering is backed by rigorous testing, a highly skilled team working in a scalable workflow, and measurement software (powered by Dragon Metrics) across four major AI platforms: ChatGPT, Google AI Overviews, Google AI Mode, and Perplexity.

Allient Inc. (Nasdaq: ALNT) (“Allient” or the “Company”), a global designer and manufacturer of precision and specialty Motion, Controls and Power products and solutions for targeted industries and applications, today announced that its Board of Directors has elected Alex Collichio as Vice President. Mr. Collichio will continue to serve as Chief Administrative Officer.

Nalgene Outdoor today introduces the Fresh Flow™ straw bottle, a new addition to its reusable bottle collection designed to give fans more ways to hydrate without sacrificing the simplicity, durability, and approachable price points they expect from a Nalgene bottle.

The return-on-equity for U.S. property/casualty (P/C) insurers reached a decade high level of 14.97% in 2025, while the cost of equity held relatively steady at 8.18%, according to a new AM Best report.

Corpay, Inc., (NYSE: CPAY), the corporate payments company, today announced that on Monday, May 18, 2026, the Company will be attending the J.P. Morgan Global Technology, Media and Communications Conference in Boston, MA. Management will participate in a fireside chat beginning at 9:05am ET.

WATERTOWN, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at two upcoming investor conferences:

CULVER CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, will hold a conference call and webcast on Wednesday, May 13, 2026 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2026.

ALBUQUERQUE, N.M., May 11, 2026 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology and fixed-tilt products, foundation solutions, software systems and services, today announced that members of its senior management team are scheduled to participate in the following investor conferences in May and June.

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to healthcare and public health management. Traditional methods such as breathalyzers, blood tests and urine screenings are often limited by their invasiveness, delayed results or inability to assess real-time impairment, particularly in cases involving multiple substances. As patterns of substance use evolve and the societal costs of impaired behavior continue to rise, the demand for faster, more scalable and noninvasive diagnostic solutions is becoming increasingly urgent. MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) (profile) is advancing a novel approach that leverages artificial intelligence (AI) and voice analysis to predict intoxication from short speech samples. By focusing on the human voice as a measurable indicator of internal physiological and cognitive states, the company is working to develop a platform capable of detecting impairment across a range of substances in real-time. This approach not only addresses a critical gap in existing detection methods but also reflects a broader shift toward AI-driven, noninvasive diagnostics with the potential to transform regulatory enforcement, workplace safety and public health outcomes. MindBio joins other key companies operating at the forefront of health, AI and diagnostics technologies, including HeartFlow Inc. (NASDAQ: HTFL), Recursion Pharmaceuticals Inc. (NASDAQ: RXRX), Tempus AI Inc. (NASDAQ: TEM) and Butterfly Network Inc. (NYSE: BFLY).

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced today that its 1st Detect TRACER 1000 system has achieved ECAC/EU G1 approval, meeting the highest European standards for aviation security. This approval reflects compliance with the European Civil Aviation Conference (“ECAC”) and European Commission requirements for trace detection systems, supporting enhanced security for airline passengers.

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving rising rates of cardiovascular disease, fatty liver disease, kidney complications and escalating healthcare costs. What began as a niche class of diabetes medications has evolved into one of the most transformative therapeutic categories in modern medicine, with GLP-1 receptor agonists now reshaping obesity treatment, metabolic care and potentially even neurodegenerative disease management. Against this backdrop, SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF), (profile) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history. SureNano is one of the emerging microcap companies operating in the GLP space, forming part of a group of companies leading the way in the GLP-1 space, including Eli Lilly and Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Amgen Inc. (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE).

Will Apply Existing Preclinical Findings in Reducing Severe Immune-Mediated Lung Failure to Potential Emerging Global Crisis

CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced activation of the Children’s Hospital of Philadelphia (CHOP) as the sixth Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel) gene-modified cellular sheets.

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced that the company will be presenting at the following conferences:

WINTER PARK, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company focused on the tokenization of commodity real-world assets, today re-released the following update to shareholders outlining recent operational progress, platform development, and the Company’s strategic outlook.

Single dose treatment of FT819 without conditioning chemotherapy achieves lupus low disease activity state (LLDAS) in active SLE Patients; durable B cell remodeling is exhibited by depletion of major B cell clones up to 12 months following treatment with B cell shift towards less class-switched BCR repertoire

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The nature of modern warfare is being rewritten in real time, driven by the rapid rise of cheap, mass-produced drones that are reshaping the economics of conflict. In war zones such as Ukraine, millions of low-cost systems, often built in small workshops or adapted from commercial designs, are now performing missions once reserved for advanced aircraft and precision-guided weapons. But while the hardware has become abundant and accessible, a critical limitation has emerged: Most of these drones lack the intelligence to operate independently in contested environments. GPS jamming, electronic warfare and the need for constant human control expose a growing gap between what drones can do and what they need to do to remain effective at scale. Increasingly, defense leaders recognize that the next phase of this revolution will not be defined by better hardware but by better software: the intelligence layer that enables autonomy, navigation, and precision without relying on vulnerable systems. SPARC AI Inc. (OTC: SPAIF) (profile) is positioning itself directly within this shift, developing a software-only platform designed to give any drone, regardless of cost or manufacturer, the ability to operate with GPS-denied navigation and precision targeting. SPARC AI is one of several companies working in the drone, AI and defense-tech space, including leaders such as Swarmer Inc. (NASDAQ: SWMR), Unusual Machines (NYSE American: UMAC), Draganfly Inc. (NASDAQ: DPRO) and Red Cat Holdings Inc. (NASDAQ: RCAT).

Axe Compute Host Conference Call and Webcast on Monday, May 18, 2026 at 8:30 a.m. Eastern Time To Review First Quarter 2026 Financial Results

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this challenge is the blood-brain barrier (BBB), a biological defense system that prevents most therapeutics from reaching the central nervous system (CNS). As Alzheimer’s disease cases rise globally and governments intensify focus on biodefense preparedness, the inability to deliver drugs effectively to the brain is emerging as a critical bottleneck in modern medicine. With this in mind, innovative companies, including Oncotelic Therapeutics Inc. (OTCQB: OTLC) (profile), are working within a broader industry shift toward advanced delivery platforms designed to bypass traditional barriers and facilitate rapid, targeted access to the brain. Oncotelic’s approach, which includes a proprietary intranasal nose-to-brain (N2B) system that enables rapid therapeutic delivery, reflects a growing recognition that solving CNS delivery, not just drug discovery, may be key to unlocking the next generation of therapies. Oncotelic joins a group of leading biopharma companies focused on cutting-edge therapeutic platforms and large-scale drug development in a range of treatment areas, including Biogen Inc. (NASDAQ: BIIB), Moderna Inc. (NASDAQ: MRNA), CytoDyn Inc. (OTCQB: CYDY) and Northwest Biotherapeutics Inc. (OTCQB: NWBO).

BARTLETT, Tenn., May 11, 2026 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG) ("SurgePays" or the "Company"), a wireless and fintech point of sale company connecting subprime and underserved consumers to essential mobile and financial services, today announced that it will host a conference call to discuss its first quarter ended March 31, 2026, on Friday, May 15, 2026. The Company will report its financial results for the 2026 first quarter the same day before the market opens.

DALLAS, May 11, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced that it will release its earnings results for the fiscal fourth quarter and year ended March 31, 2026, on Tuesday, May 26, 2026, before the market opens. The Company will host a conference call the same day at 10:00 am Eastern Time to discuss the results.

Organization offers expert voices on implications for rule of law and dispute resolution

Rialtic, a cloud-based enterprise platform for healthcare payment accuracy, and Exponential AI, a leader in real-time healthcare AI decision intelligence, today announced a definitive agreement to merge the two organizations, bringing together two of the industry’s most consequential innovators in agentic learning and claims intelligence. This strategic move creates a unified platform designed to meet the evolving needs of healthcare payers and providers by combining deep payment accuracy expertise with advanced agentic technology. Moreover, it arrives at a pivotal moment, in which payers and providers are working to make healthcare meaningfully more affordable for American families and employers.

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the commencement of 20 separate offers, for its own account and on behalf of certain of its wholly-owned subsidiaries, to purchase for cash (i) any and all of the debt securities listed in Table 1 below (the “Any and All Notes” and such offers, the “Any and All Tender Offers”) and (ii) up to $1.25 billion aggregate purchase price of the outstanding series of debt securities listed in Table 2 below (the “Waterfall Notes” and, together with the Any and All Notes, the “Notes” and such offers, the “Waterfall Tender Offers” and, together with the Any and All Tender Offers, the “Tender Offers”), on the terms and subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement dated May 11, 2026 (the “Offer to Purchase and Consent Solicitation Statement” and, together with the accompanying letter of transmittal, the “Offer Documents”). Concurrently with the Tender Offers, Verizon, on behalf of certain of its wholly-owned subsidiaries, is soliciting consents (the “Consent Solicitations”) to the proposed amendments (the “Proposed Amendments”) to the indentures governing the Any and All Notes issued by such subsidiaries (the “Existing Indentures”) in order to, among other things, eliminate certain of the restrictive covenants contained therein, on the terms and subject to the conditions set forth in the Offer Documents. If a Holder (as defined below) validly tenders Any and All Notes in a Tender Offer, such Holder will be deemed to deliver its consent, with respect to the principal amount of such tendered Any and All Notes, to the Proposed Amendments. Holders may neither deliver their consents in a particular Consent Solicitation without tendering Any and All Notes in the related Tender Offer, nor may they tender Any and All Notes in a particular Tender Offer without delivering their consents with respect to such Any and All Notes in the related Consent Solicitation. The completion of any Tender Offer with respect to a series of Any and All Notes is not conditioned on the receipt of the requisite consents in the related Consent Solicitation.

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the commencement of offers to exchange (the “Exchange Offers”), on behalf of certain of its wholly-owned subsidiaries, any and all of the outstanding series of debt securities listed below (the “Old Notes”) for specified series of newly issued notes of Verizon (collectively, the “New Notes”) on the terms and subject to the conditions set forth in the Exchange Offer and Consent Solicitation Statement dated May 11, 2026 (the “Exchange Offer and Consent Solicitation Statement” and, together with the accompanying letter of transmittal (the “Letter of Transmittal”) and eligibility letter, the “Exchange Offer Documents”). Concurrently with the Exchange Offers, Verizon, on behalf of such subsidiaries, is soliciting consents (the “Consent Solicitations”) to the proposed amendments (the “Proposed Amendments”) to the indentures governing the Old Notes (the “Existing Indentures”) in order to, among other things, eliminate certain of the restrictive covenants contained therein, on the terms and subject to the conditions set forth in the Exchange Offer Documents. If an Eligible Holder (as defined below) validly tenders Old Notes in an Exchange Offer, such Eligible Holder will be deemed to deliver its consent, with respect to the principal amount of such tendered Old Notes, to the Proposed Amendments. Eligible Holders may neither deliver their consents in a particular Consent Solicitation without tendering Old Notes in the related Exchange Offer, nor may they tender Old Notes in a particular Exchange Offer without delivering their consents with respect to such Old Notes in the related Consent Solicitation. The completion of any Exchange Offer is not conditioned on the receipt of the requisite consents in the related Consent Solicitation.

CARE aims to deliver up to one million modern CARE PACKAGE kits, reaching two million people worldwide and in the United States, by 2030.

Today, SharonAI Holdings Inc. (NASDAQ: SHAZ) and its subsidiaries (“Sharon AI” or the “Company”), a leading Australian Neocloud, announced that it will host a conference call and webcast on Friday, May 15, 2026, at 4:30 p.m. Eastern Time to review the Company’s results for the first quarter ended March 31, 2026. The Company will release its first quarter 2026 financial results that day after the market closes.

BASSETERRE, ST. KITTS AND NEVIS / ACCESS Newswire / May 11, 2026 / The third edition of the Investment Gateway Summit (IGS) 2026 in St. Kitts and Nevis is set to take place from 17-20 June 2026. The summit is expected to position the Federation at the centre of global investment dialogue, bringing together investors, policymakers, and industry leaders from across the world.